Patent · US Expired

Matrix metalloprotease inhibitors

US6350907B1 · kind B1 · utility

2Cited by
2References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2000
Grant dateFeb 26, 2002
Priority date—
Expiry dateApr 11, 2020

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I): or pharmaceutically acceptable salts thereof, or solvates of either entity, wherein the substituents have the values described herein, are useful as matrix metalloprotease (MMP) inhibitors

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.